Q1 2026 Management View CEO Paul Romanowski stated that the company began fiscal 2026 with "consolidated pretax income of ...
Q4 2025 Management View Gunjan Kedia, President, CEO & Director, reported "earnings per share of $1.26, an increase of approximately 18% year-over-year on an adjusted basis" and record net revenues of ...
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating ...
AstraZeneca’s $80 billion revenue target for 2030 is “very much within reach,” Chief Fin | While the $80 billion revenue ...
While Moderna’s full-year sales landed in the upper end of its target range, Jefferies analysts said further reductions are ...
Teknova is "reiterating 2025 total revenue guidance of $39 million to $42 million." Lowell noted, "Based on persistent softness in demand for our Clinical Solutions products from biopharma customers, ...
The National Board of Revenue (NBR) recorded a significant revenue shortfall in the first half of the 2025-26 fiscal year, ...